Liftr Insights, a pioneer in market intelligence driven by unique data, released an article outlining the numbers behind ARM growth in the major cloud ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

TD Cowen analyst Ryan Langston maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $391.00. The company’s ...

TD Cowen upgraded Roper Technologies (ROP) to Buy from Hold with a price target of $615, up from $535. Given macroeconomic and policy ...

TD Cowen analysts increased the price target for Synchrony Financial (NYSE:SYF) shares to $80.00, up from the previous $75.00, while reiterating a Buy rating. The adjustment follows Synchrony ...

Fintel reports that on January 28, 2025, TD Cowen upgraded their outlook for Roper Technologies (NasdaqGS:ROP) from Hold to ...

TD Cowen's model also assumes that capital expenditures (Capex) will remain at 6% of sales, with a return on invested capital (ROIC) of 23%, which is among the highest in the firm's coverage of ...

For detailed analysis of DKS's financial health and growth prospects, including comprehensive valuation models and peer comparisons, explore the full research report available on InvestingPro. TD ...

Investing.com -- TD Cowen upgraded SAP SE ADR (NYSE:SAP) stock to Buy from Hold and raised its price target to $305 from $240. Analysts at the bank cited SAP's resilient stock appreciation and ...

Investing.com-- TD Cowen analysts increased their price target for American Airlines Group (NASDAQ:AAL) citing management’s optimism, stronger corporate sales recovery, and progress in reducing ...

However, TD Cowen analysts believe that the company's near-term financial performance is likely to be subdued due to inventory pressures and less favorable demand in the automotive and industrial ...

Investing.com -- TD Cowen downgraded Celsius Holdings (NASDAQ:CELH) to Hold and slashed its price target for the stock to $29 from $40 in a note Wednesday, citing slowing sales growth, intensifying ...